We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Eli Lilly, Elan Get $8M In Fees After Alzheimer's IP Win

Law360, Los Angeles (April 18, 2016, 10:53 PM EDT) -- A California federal judge on Friday ordered the Alzheimer's Institute of America to pay Eli Lilly and Elan Pharmaceuticals roughly $8 million in attorneys' fees after losing a suit backed by an “ego and greed” driven scheme to misrepresent the true owner of a patent covering Alzheimer's detection.

U.S. District Judge Elizabeth D. LaPorte's ruling awarded Eli Lilly & Co. $4,445,492 and Elan Pharmaceuticals Inc. $3,435,130 for their work successfully defending the patent infringement suit. The ruling solely concerned the amount of attorneys' fees AIA would...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.